Publications

Export 1220 results:
Sort by: Author Title Type [ Year  (Desc)]
Submitted
Victoria, S., H. Amaral, I. Mulamitsi, S. Bhatnagar, H. Moustafa, H. Kartunihardja, F. Sundram, and K. Britton, "CRF on in vivo imaging for infection (sepsis) and inflammation", European Congress Nuclear Medicine, Berlin, 29 Aug- 4 Sept, Submitted.
Mohamed, G., P. Murray, E. Nagy, and K. Vrzalikova, "Epstein–Barr virus, the germinal centre and the development of Hodgkin’s lymphoma", Journal of General Virology, vol. 95, issue 10.1099/vir.0.066712-0, pp. 1861–1869, Submitted. 1861.full_.pdf
Sakr, O. G., R. M. García-García, M. Arias-Álvarez, P. L. Lorenzo, P. Millán, B. Velasco, P. G. Rebollar, I. Badiola, A. Pérez de Rozas, and D. Menoyo, 9 de Febrero de 2012, , Submitted. Abstract
n/a
Agarwal, R. P., S. R. Grace, D. O'Regan, S. Albeverio, S. Kuzhel, L. Nizhnik, M. O. Androwuk, M. GS, A. A. Val, and A. A. Vict, "Alfavitnyj pokaΩçyk 59-ho tomu „Ukra] ns\koho matematyçnoho Ωurnalu”", differential equations, vol. 3, pp. 291, Submitted. Abstract
n/a
Adly, A., D. Davino, A. Giustiniani, and C. Visone, Details of selected paper, , Submitted. Abstract
n/a
Adly, A., D. Davino, A. Giustiniani, and C. Visone, Details of selected paper, , Submitted. Abstract
n/a
Clemente, C. S., A. Mahgoub, D. Davino, and C. Visone, EQUIVALENTE 3-PORTE DI UN DISPOSITIVO DI ENERGY HARVESTING, , Submitted. Abstract
n/a
Addis, T. R., B. Visscher, J. J. T. Addis, A. Gegov, G. Galal, and N. Clarke, Exploring {Architectural} {Modelling} to {Understand} {System} {Evolution}, , Submitted. Abstract
n/a
O’GRADY, K. E. V. I. N., C. E. Patton, R. H. Victora, R. S. Indeck, D. Melton, B. Dieny, R. Hasegawa, D. C. Jiles, T. D. Lee, Y. Miura, et al., IEEE MAGNETICS SOCIETY, , Submitted. Abstract
n/a
d’Aquino, M., C. Serpico, C. Visone, and A. Adly, Modelli matematici di isteresi basati su una nuova classe di isteroni Play, , Submitted. Abstract
n/a
Bhangu, A., A. O. Ademuyiwa, M. L. Aguilera, P. Alexander, S. W. Al-Saqqa, G. Borda-Luque, A. Costas-Chavarri, T. M. Drake, F. Ntirenganya, E. J. Fitzgerald, et al., "Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study", The Lancet Infectious DiseasesThe Lancet Infectious Diseases: Elsevier, Submitted. AbstractWebsite

BackgroundSurgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world.BackgroundSurgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world.

Abdel-Aziz, H., W. Wadie, D. M. Abdallah, B. Vinson, O. Kelber, D. Weiser, and M. T. Khayyal, "Wirkung von STW 5 in einem experimentellen Kolitis-Modell", Zeitschrift für Gastroenterologie, vol. 46, issue 09, pp. P362, Submitted. Abstract
n/a
Ahmed, A. A., A. A. Mohamed, I. A. Guled, H. M. Elamin, A. H. Abou-Zeid, J. Loko Roka, R. Van den Bergh, S. Au, E. De Plecker, R. Zachariah, et al., Womens/Reproductive Health:[32], , Submitted. Abstract
n/a
In Press
Veeramachaneni, C., and et al, "Retreatment efficacy of propoint and guttapercha- A cone beam computed tomography analysis. (Prof. Emad was a peer reviewer for this article).", British Journal of Medicine and Medical Research, In Press.
2022
Periyasamy, S., V. Karthik, P. Senthil Kumar, B. J. Isabel, T. Temesgen, B. M. Hunegnaw, B. B. Melese, B. A. Mohamed, and D. - V. N. Vo, Chemical, physical and biological methods to convert lignocellulosic waste into value-added products. A review, , vol. 20, issue 2, pp. 1129 - 1152, 2022. AbstractWebsite

Actual agricultural practices produce about 998 million tonnes of agricultural waste per year. Therefore, converting lignocellulosic wastes into energy, chemicals, and other products is a major goal for the future circular economy. The major challenge of lignocellulosic biorefineries is to transform individual components of lignocellulosic biomass into valuable products. Here we review lignocellulosic biomasses such as coffee husk, wheat straw, rice straw, corn cob, and banana pseudostem. We present pretreatment technologies such as milling, microwave irradiation, acidic, alkaline, ionic liquid, organosolv, ozonolysis, steam explosion, ammonia fiber explosion, and CO2 explosion methods. These methods convert biomass into monomers and polymers. For that, the concoction pretreatment methods appear promising.

Lackner, M., S. G. de Hoog, L. Yang, L. F. Moreno, S. A. Ahmed, F. Andreas, J. Kaltseis, M. Nagl, C. Lass-Flörl, B. Risslegger, et al., Correction to: Proposed nomenclature for Pseudallescheria, Scedosporium and related genera, , vol. 113, issue 1, pp. 193 - 194, 2022. AbstractWebsite
n/a
Méndez-Sánchez, N., E. Bugianesi, R. G. Gish, F. Lammert, H. Tilg, M. H. Nguyen, S. K. Sarin, N. Fabrellas, S. Zelber-Sagi, J. - G. Fan, et al., "Global multi-stakeholder endorsement of the MAFLD definition", The Lancet Gastroenterology & HepatologyThe Lancet Gastroenterology & Hepatology, vol. 7, issue 5: Elsevier, pp. 388 - 390, 2022. AbstractWebsite
n/a
Quirke, J. C. K., G. C. Sati, A. Sonousi, M. Gysin, K. Haldimann, E. C. Böttger, A. Vasella, S. N. Hobbie, and D. Crich, "Structure-Activity Relationships for 5′′ Modifications of 4,5-Aminoglycoside Antibiotics", ChemMedChem, vol. n/a, issue n/a: John Wiley & Sons, Ltd, pp. e202200120, 2022. AbstractWebsite

Abstract Modification at the 5??-position of 4,5-disubstituted aminoglycoside antibiotics (AGAs) to circumvent inactivation by aminoglycoside modifying enzymes (AMEs) is well known. Such modifications, however, unpredictably impact activity and affect target selectivity thereby hindering drug development. A survey of 5??-modifications of the 4,5-AGAs and the related 5-O-furanosyl apramycin derivatives is presented. In the neomycin and the apralog series, all modifications were well-tolerated, but other 4,5-AGAs require a hydrogen bonding group at the 5??-position for maintenance of antibacterial activity. The 5??-amino modification resulted in parent-like activity, but reduced selectivity against the human cytosolic decoding A site rendering this modification unfavorable in paromomycin, propylamycin, and ribostamycin. Installation of a 5??-formamido group and, to a lesser degree, a 5??-ureido group resulted in parent-like activity without loss of selectivity. These lessons will aid the design of next-generation AGAs capable of circumventing AME action while maintaining high antibacterial activity and target selectivity.

Alnjiman, F., A. Virfeu, D. Pilloud, S. Diliberto, E. Haye, A. E. Giba, S. Migot, J. Ghanbaja, P. Boulet, H. Albrithen, et al., Theoretical and experimental approaches for the determination of functional properties of MgSnN2 thin films, , vol. 244, pp. 111797, 2022. AbstractWebsite

MgSnN2 thin films were deposited by reactive magnetron co-sputtering on fused silica and silicon substrates. The properties of the films were determined as a function of the deposition temperature. Although the films exhibited a strong preferred orientation along the [002] direction, cumulative X-ray diffractograms at various χ angles evidenced that the deposited films crystallized in a wurtzite-like structure. Regardless of the substrate temperature during deposition, MgSnN2 films had a columnar microstructure. Mössbauer spectrometry and X-ray photoemission spectroscopy were used to extract the chemical environment of magnesium and tin atoms and to identify their oxidation states. Electrical properties were deduced from Hall effect measurements. An increase of the electron mobility was noticed at high deposition temperature. The optical band gap of MgSnN2 films increased from approx. 2.28 to 2.43 eV in the 300–500 °C range. The experimental optical properties of MgSnN2 films were compared to those obtained by ab initio calculations.

Hernández-Molina, G., B. Kostov, P. Brito-Zerón, A. Vissink, T. Mandl, A. C. Hinrichs, L. Quartuccio, C. Baldini, R. Seror, A. Szántó, et al., "Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.", Rheumatology (Oxford, England), 2022. Abstract

OBJECTIVE: To characterize 414 patients with primary SS who developed hematological malignancies and to analyze how the main SS- and lymphoma-related features can modify the presentation patterns and outcomes.

METHODS: By January 2021, the Big Data Sjögren Project Consortium database included 11 966 patients fulfilling the 2002/2016 classification criteria. Hematological malignancies diagnosed according to the World Health Organization (WHO) classification were retrospectively identified.

RESULTS: There were 414 patients (355 women, mean age 57 years) with hematological malignancies (in 43, malignancy preceded at least one year the SS diagnosis). 376 (91%) patients had mature B cell malignancy, nearly half MALT lymphoma (n = 197), followed by DLBCL (n = 67), nodal MZL lymphoma (n = 29), CLL/SLL (n = 19) and follicular lymphoma (n = 17). Rates of complete response, relapses and death were 80%, 34% and 13%, respectively, with a 5-year survival rate of 86.5% after a mean follow-up of 8 years. There were significant differences in age at diagnosis (younger in MALT, older in CLL/SLL), predominant clinical presentation (glandular enlargement in MALT lymphoma, peripheral lymphadenopathy in nodal MZL and FL, constitutional symptoms in DLBCL, incidental diagnosis in CLL/SLL), therapeutic response (higher in MALT lymphoma, lower in DLBCL) and survival (better in MALT, nodal MZL and FL, worse in DLBCL).

CONCLUSION: In the largest reported study of hematological malignancies complicating primary SS, we confirm the overwhelming predominance of B cell lymphomas, especially MALT, with the salivary glands being the primary site of involvement. This highly-specific histopathological scenario is linked with the overall good prognosis with a 5-year survival rate of nearly 90%.

Prabu, P., K. Venkatachalam, A. S. Alluhaidan, R. Marzouk, M. Hadjouni, and S. A. El_Rahman, "Covid-19 CT Lung Image Segmentation Using Adaptive Donkey and Smuggler Optimization Algorithm", Computers, Materials & Continua, vol. 71, issue 1, pp. 1133-1152, 2022.
Sen, P., L. Gupta, J. B. Lilleker, V. Aggarwal, S. Kardes, M. Milchert, T. Gheita, B. Salim, T. Velikova, A. E. Gracia-Ramos, et al., "COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.", Rheumatology international, vol. 42, issue 1, pp. 23-29, 2022. Abstract

The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.